United States · FDA National Drug Code directory

Rizatriptan Benzoate

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
71335-2982_f8d2892f-9943-4084-9b22-d1eabc695ac3
Product NDC
71335-2982
Form
TABLET, ORALLY DISINTEGRATING
Composition / generic term
Rizatriptan Benzoate
Labeler
Bryant Ranch Prepack
Marketing category
ANDA
Marketing start / end (source format)
20130701
Source listing expiry
20271231

Source-listed ingredients

  • RIZATRIPTAN BENZOATE — 10 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 9 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (71335-2982-1) · 71335-2982-1

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →